NEW YORK (GenomeWeb News) – Agilent Technologies will supply microarrays to Signature Genomic Laboratories and its customers under a new long-term agreement, Signature said today.
Under the agreement, Agilent will supply Signature and customers using the SignatureChip Oligo Solution with its custom oligonucleotide microarrays, the Spokane, Wash.-based company said.
The SignatureChip OS is used in detecting chromosome abnormalities in individuals with mental retardation/developmental delay, autism, and congenital abnormalities.
The company said the agreement also allows users of its Genoglyphix software to use the oligo arrays in their research applications.
Signature offers its microarray-based cytogenetic diagnostic and chromosome analysis products to clinical geneticists, neurologists, pediatricians, and other physicians and researchers.
Financial terms of the agreement were not released.